NEW
Font size
WorksheetsAntiviral Drugs
Total questions: 28
Worksheet time: 18mins
A 30-year-old male patient with human immuno- deficiency virus infection is being treated with a HAART (highly active antiretroviral therapy) regimen. Four weeks after initiating therapy, he presents to the emergency department complaining of fever, rash, and gastrointestinal upset. Which one of the following drugs is most likely the cause of his symptoms?
Zidovudine
Nelfinavir
Abacavir
Efavirenz
Darunavir
A 75-year-old man with chronic obstructive pulmonary disease is diagnosed with suspected influenza based on his complaints of flu-like symptoms that began 24 hours ago. Which of the following agents is most appropriate to initiate for the treatment of influenza?
Ribavirin
Oseltamivir
Zanamivir
Rimantadine
Amantadine
A 24-year-old female is diagnosed with genital herpes simplex virus infection. Which of the following agents is indicated for use in this diagnosis?
Valacyclovir
Cidofovir
Ganciclovir
Zanamivir
Lamivudine
A female patient who is being treated for chronic hepatitis B develops nephrotoxicity while on treatment. Which is the most likely medication she is taking for HBV treatment?
Entecavir
Telbivudine
Lamivudine
Adefovir
Which statement about the mechanisms of action of antiviral drugs is accurate?
Acyclovir has no requirement for activation by phosphorylation
Ganciclovir inhibits viral DNA polymerase but does not cause chain termination
Increased activity of host cell ribonucleases that degrade viral mRNA is one of the actions of interferon-α
The initial step in activation of foscarnet in HSV- infected cells is its phosphorylation by thymidine kinase
The reverse transcriptase of HIV is 30–50 times more sensitive to inhibition by fosamprenavir than host cell
DNA polymerases
A 30-year-old male patient who is HIV- positive and symptomatic has a CD4 count of 250/μL and a viral RNA load of 15,000 copies/mL. His treatment involves a 3-drug antiviral regimen consisting of zidovudine, didanosine, and ritonavir. The patient is taking acyclovir for a herpes infection and ketoconazole for oral candidiasis. He now complains of anorexia, nausea and vomiting, and abdominal pain. His abdomen is tender in the epigastric area. Laboratory results reveal an amylase activity of 220 U/L, and a preliminary diagnosis is made of acute pancreatitis. If this patient has acute pancreatitis, the drug most likely to be responsible is
Acyclovir
Didanosine
Ketoconazole
Ritonavir
Zidovudine
A 30-year-old male patient who is HIV- positive and symptomatic has a CD4 count of 250/μL and a viral RNA load of 15,000 copies/mL. His treatment involves a 3-drug antiviral regimen consisting of zidovudine, didanosine, and ritonavir. The patient is taking acyclovir for a herpes infection and ketoconazole for oral candidiasis. He now complains of anorexia, nausea and vomiting, and abdominal pain. His abdomen is tender in the epigastric area. Laboratory results reveal an amylase activity of 220 U/L, and a preliminary diagnosis is made of acute pancreatitis. In the further treatment of this patient, the drug causing the pancreatitis should be withdrawn and replaced by
Atazanavir
Cidofovir
Foscarnet
Lamivudine
Ribavirin
In an accidental needlestick, an unknown quantity of blood from an AIDS patient is injected into a resident physician. The most recent laboratory report on the AIDS patient shows a CD4 count of 20/μL and a viral RNA load of greater than 107 copies/mL. The most appropriate course of action regarding treatment of the resident is to
Determine whether HIV transmission has occurred by monitoring the patient’s blood
Treat with a single high dose of zidovudine
Treat with full doses of zidovudine for 4wk
Treat with single doses of zidovudine and indinavir
Treat with zidovudine + lamivudine + ritonavir for 4wk
A patient with AIDS has a CD4 count of 45/μL. He is being maintained on a 3-drug regimen of indinavir, didanosine, and zidovudine. For prophylaxis against opportunistic infections, he is also receiving cidofovir, fluconazole, rifabutin, and trimethoprim-sulfamethoxazole. The drug most likely to suppress herpetic infections and provide prophylaxis against CMV retinitis in this patient is
Fluconazole
Cidofovir
Indinavir
Rifabutin
Trimethoprim-sulfamethoxazole
A patient with AIDS has a CD4 count of
45/μL. He is being maintained on a 3-drug regimen of indinavir, didanosine, and zidovudine. For prophylaxis against opportunistic infections, he is also receiving cidofovir, fluconazole, rifabutin, and trimethoprim-sulfamethoxazole. The dose of indinavir in this patient may need to be increased above normal. This is because
Fluconazole slows gastric emptying
Ganciclovir increases the renal clearance of indinavir
Gastric absorption is inhibited by fluconazole
Rifabutin increases hepatic drug metabolism
Sulfamethoxazole increases indinavir plasma protein binding
A 27-year-old nursing mother is diagnosed as suffering from genital herpes. She has a history of this viral infection. Previously, she responded to a drug used topically. Apart from her current problem, she is in good health. Which drug to be used orally is most likely to be prescribed at this time?
Amantadine
Foscarnet
Ritonavir
Trifluridine
Valacyclovir
Oral formulations of this drug should not be used in a pregnant AIDS patient because they contain propylene glycol. One of the characteristic adverse effects of the drug is hyperpigmentation on the palms of the hands and soles of the feet, especially in African-American patients.
Amprenavir
Emtricitabine
Efavirenz
Fosamprenavir
Zalcitabine
Which of the following statements about interferon-α is false?
At the start of treatment, most patients experience flu-
like symptoms
Indications include treatment of genital warts
It is used in the management of hepatitis B and C
Lamivudine interferes with its activity against hepatitis B
Toxicity includes bone marrow suppression
More than 90% of this drug is excreted in the urine in intact form. Because its urinary solubility is low, patients should be well hydrated to prevent nephrotoxicity. Which drug is described?
Acyclovir
Efavirenz
Indinavir
Trifluridine
Zidovudine
A man with HIV infection is taking an agent that pre- vents viral maturation. Which adverse effect is typically associated with this type of drug?
anemia
pancreatitis
neuropsychiatric reactions
peripheral neuropathy
lipodystrophy
A patient with shingles receives a drug that is converted to penciclovir in the body. Which antiviral action is exerted by this agent?
blockade of purine biosynthesis
inhibition of DNA polymerase
inhibition of viral entry
DNA chain termination
prevention of viral maturation
A woman with an upper respiratory infection is treated with an agent that is administered by nasal inhalation. Which step in viral replication is prevented by this drug?
entry into host cells
uncoating of viral nucleic acid
replication of viral nucleic acid
maturation of viral proteins
release of progeny virions
A man with immunodeficiency syndrome being treated for a severe herpesvirus infection develops acute renal insufficiency and tachycardia. Which drug is he most likely receiving?
foscarnet
trifluridine
acyclovir
famciclovir
ganciclovir
A 78-year-old man presents for evaluation of a painful rash. He reports a sharp, burning pain radiating from his midback to his left side. He noticed a “rash” that spread “like a line” in the same area where he had pain. The rash has a dermatomal distribution from his spine around the left flank to the midline of the abdomen. It has erythematous patches with clusters of vesicles. He reports a history of chickenpox as a child. Among the following, which would be the most appropriate agent to prescribe?
Abacavir
Entecavir
Famciclovir
Oseltamivir
Rimantadine
A 25-year-old man was recently diagnosed with genital herpes and was prescribed acyclovir. Although acyclovir is well distributed into most cells throughout the body, it is more active in herpesvirus (HSV)–infected cells. Which of the following mechanisms best accounts for the selective action of acyclovir in HSV-infected cells as compared with uninfected cells?
Competitive inhibition of viral thymidine kinase by acyclovir.
Greater affinity of acyclovir triphosphate for cellular DNA polymerase.
Greater inhibition of viral DNA repair enzymes.
Inability to be converted to acyclovir triphosphate in virus-infected cells.
Preferential conversion to acyclovir monophosphate in virus-infected cells.
Which of the following drugs is indicated for the treatment of either influenza A or influenza B?
Amantadine
Foscarnet
Oseltamivir
Ribavirin
Rimantadine
A patient is being treated for hepatitis C. Which drug combination would be the preferred treatment to eradicate the viral infection?
Acyclovir and valganciclovir.
Ribaviron and interferon alfa.
Ledipasvir and sofosbuvir.
Palivisumab and tenofovir.
Cidofovir and valacyclovir.
Which nucleoside analogue that was used previously to treat HIV is now used to treat resistant forms of hepatitis B?
Zanamivir
Valganciclovir
Lamivudine
Adefovir dipivoxil
Acyclovir
An HIV-positive patient has been treated with FTC-TDF and efavirenz for the past 3 years, and plasma HIV RNA levels have been undetectable. However, recent plasma RT-PCR reveals that her HIV RNA levels are greater than 20,000 copies/mL. A new regimen was proposed that included abacavir, lamivudine, and raltegravir. One year later, the patient's HIV RNA level is again found to be elevated with 50,000 copies/mL. Which of the following most likely describes the reason for the failure of this second regimen?
The second regimen contained abacavir, which is not indicated for the treatment of HIV infections.
The second regimen contained an NRTI that was cross-resistant with FTC.
The second regimen contained all protease inhibitors.
The second regimen did not contain ritonavir.
The second regimen did not include a boosting agent.
A 25-year-old man was recently diagnosed with HIV infection and presents to you for treatment. He has also had diabetes mellitus since childhood and has renal insufficiency as a result, with a glomerular filtration rate of only 20 mL/min. Which drug should be avoided in this patient?
Tenofovir disoproxil
Abacavir
Ritonavir
Efavirenz
Raltrgravir
Which of the following drugs is indicated for the treatment of either HIV or hepatitis B?
Tenofovir
Etravirine
Abacavir
Ritonavir
Entecavir
Which of the following drugs does not need to be administered with a boosting agent?
Darunavir
Dolutegravir
Atazanavir
Elvitegravir
Lopinavir
Treatment of HIV typically involves the use of three active agents and a “boosting” agent such as cobicistat. The efficacy of the booster is due to its ability to inhibit
P-glycoprotein
Viral fusion
Virion assembly
Glucuronidation
CYP3A4
